The Long Island Capital Alliance Announces Participants for Healthcare Capital Forum to be Held on November 7, 2014

October 16, 2014 10:04 AM | Deleted user

 

Melville, NY –  October 16, 2014 The Long Island Capital Alliance (“LICA”), Long Island’s  leading non-profit capital formation and business development organization, today announced the presenting companies and investor panelists for its Healthcare Capital Forum to be held on Friday, November 7, 2014.  The capital forum will help accelerate the growth of healthcare businesses on Long Island.

Five local healthcare products and services companies will present their business plans to an audience that will include venture capital firms, investment banks, private equity firms, angel and individual investors.  Each of the companies LICA selected for presentation at the capital forum possesses unique intellectual properties with catalysts for significant growth.

Healthcare Capital Forum on November 7, 2014 – Participants

Panel of Investors

The following investment professionals will participate in the investor panel at the Healthcare Capital Forum:

David Calone, Jove Equity Partners:  David Calone is the CEO of Jove Equity Partners, LLC, a firm that manages private equity and venture capital investments. He serves on the Board of Directors of eight privately-held companies. Mr. Calone previously served as a federal prosecutor in the U.S. Department of Justice’s Honors Program where he received a 2003 Attorney General’s Award for his work in fighting terrorism-related and corporate international crime. Mr. Calone also served as a Special Assistant Attorney General in the New York State Attorney General’s Office and was an associate at Paul Weiss Rifkind Wharton & Garrison in New York. He has a degree in economics from Princeton University and received a J.D. from Harvard Law School.

William Ho, AlephPoint Capital:  William Ho founded AlephPoint Capital, a healthcare equity hedge fund, in 2014.  Prior to AlephPoint, in 2010 he joined New Leaf Venture Partners, a leading healthcare venture capital fund, to launch the firm’s efforts in the public equities markets. Previously, he has held senior positions on a derivatives trading desk of ICAP plc, as an equity research analyst covering the biotechnology industry at Bank of America, and at Piper Jaffray & Co. covering the biotechnology and life-sciences tools sectors.  Earlier in his career, Mr. Ho held an operational role at CuraGen Corporation, a genomics biotechnology company, where he twice restructured the company, and was an associate in the healthcare investment banking group at SG Cowen. He holds an MBA from the University of Notre Dame and a BS in Biochemistry from McMaster University in Canada.

Antony E. Pfaffle, M.D., CorMedix Inc.:  Dr. Antony E. Pfaffle is Chief Scientific Officer of CorMedix, Inc., a specialty pharmaceutical company. Dr. Pfaffle is the Advisory Chief Medical Officer at ParagonRx, which creates pharmaceutical safe programs. He has been the Director of Healthcare Research at Bearing Circle Capital, L.P., an investment fund, since May 2007.  He was a Managing Director at Paramount BioCapital, Inc. and Senior Vice-President of Business Development at Paramount BioSciences, LLC from December 2005 to May 2007.  Dr. Pfaffle was a Principal and Founder of Black Diamond Research, an investment research company, from July 2001 to December 2005.  He is an internist who practiced nephrology at New York Hospital, Lenox Hill and Memorial Sloan-Kettering, and received his M.D. degree from New York Medical College in 1989.

Clayton Besch III, Empire State Development:  Clayton Besch is Director of the Small Business Technology Investment Fund (SBTIF) at Empire State Development. The SBTIF provides early stage high-tech companies throughout New York with a potential source of venture capital to promote new job creation and economic growth. Previously, Mr. Besch worked at the New York State (NYS) Department of Economic Development, where he ran the Asian Office, introducing NYS companies to sales opportunities in Japan and Korea and introducing Japanese companies to strategic opportunities in NYS. He also spent a number of years at SOFTBANK INC. as development advisor, working with SOFTBANK’s worldwide VC network, including GrandBanks Capital, Mobius Ventures and SOFTBANK Capital Partners. Mr. Besch is currently an observer on the boards of e2e Materials and Float Tech Inc. Mr. Besch holds a BS from Hamilton College in NYS, an MS from Nagasaki University and a PhD from Tokyo University.

Delphine Mendez de Leon, Huron Consulting:  Delphine Mendez de Leon is Managing Director of Wellspring+Stockamp for Huron Healthcare at Huron Consulting Group Inc.  She has extensive healthcare experience in operations, strategic and financial planning, and business development. Since 2001, she also has been a manager at Cap Gemini Ernst & Young, Inc., a healthcare strategy transformation consulting firm, where she manages healthcare system strategy transformation, ... span of control and overhead improvement efforts, and served in various capacities with The Brooklyn Hospital Center and Long Island-based American Medical Alert Corp.  Ms. Mendez de Leon holds an MBA from Columbia University School of Business and a Masters in Public Health from Columbia University School of Public Health.

Presenting Companies

AdMedDev:  Affiliated with Stony Brook University, AdMedDev provides advanced sensors and wireless medical electronic devices used in tracking and analyzing data associated with medical specimens.  The market size for this business is estimated at $3 billion and may service over 7,500 hospital and large health care providers.

 Anschel Technology: Founded in 2011, Anschel produces the SightSaver™, a patented FDA approved device for eliciting visual evoked physiological responses.  There are over 2 million operations performed annually that can cause post-operative visual loss.  SightSaver provides a hygienic, safe, comfortable, and effective alternative to current solutions.  

PAXmed: As creator of four venture backed medical device companies, the company is a vehicle to accelerate the development of device start-ups utilizing capital efficiency strategies to enhance value creation and return on invested capital.

Symbiotic Health: Develops powerful microbiome-based therapeutics to cure and prevent infection caused by the depletion of symbiotic microbes due to antibiotics, addressing a $4.8 billion market.

Traverse Biosciences:  Based out of Stony Brook University’s Center for Biotechnology, Traverse is commercializing a proprietary pipeline of drug candidates to treat inflammatory diseases and agerelated conditions affecting humans and companion animals.  FDA approval is being sought for a lead drug intended to prevent canine periodontal disease.

LICA is hosting the Healthcare Capital Forum on Friday, November 7, 2014 from 8:00 a.m. to 10:45 a.m. at 68 South Service Road, Melville, NY.  The capital forum provides an opportunity to meet capital providers, entrepreneurs, industry executives and businesses seeking capital, as well as to hear a panel of industry experts discuss financing alternatives for healthcare products and services companies.

For more information about the event, please contact LICA today or register online.

About the Long Island Capital Alliance

Since 1984, the Long Island Capital Alliance (www.licapital.org), formerly known as Long Island Venture Group, has been promoting business growth on Long Island.  LICA seeks to create a productive and business-friendly environment that will afford area businesses access to the resources necessary to compete successfully in today’s markets.  LICA serves as a focal point for the exchange of ideas among new and existing business enterprises, successful entrepreneurs, investors, and service providers.  Through quarterly capital forums and special meetings, LICA brings together members of the region’s business community, and has been recognized as the place to turn to when small businesses need equity, debt, or other financing, or for investors to find an attractive investment opportunity.

LICA’s mission is to encourage economic development on Long Island by facilitating capital formation for a broad range of companies in various industries, from early stage to mature, middle market, closely held and publicly-traded businesses.  LICA accomplishes this primarily through education, networking, quarterly capital forums, periodic special educational meetings, and alliances with other regional organizations.  LICA brings together members of the region's business community and serves as the finance arm for significant local business and organizations.

For more information on LICA and its next event, please contact LICA today or register online.

 

* * *

Contact:

Jordan Darrow

Darrow Associates, Inc.

(631) 367-1866

jdarrow@darrowir.com

 

Platinum Sponsors
   Carter DeLuca Farrell Schmidt, LLP    

      
Gold Sponsors
         
Sponsors
   Executive Strategies Group LLC

Powered by Wild Apricot Membership Software